上海医药：控股股东上实集团计划增持5500万股至7400万股公司H股股份

Core Viewpoint - Shanghai Pharmaceuticals (601607.SH) announced that its controlling shareholder, Shanghai Industrial (Group) Co., Ltd., plans to increase its stake in the company’s H-shares through its wholly-owned subsidiary, Shanghai International Investment Co., Ltd. [1] Group 1 - The planned increase in shares will range from 55 million to 74 million shares [1] - The total shares to be acquired will not exceed 2% of the company's voting shares [1]